Germany's Merck KGaA has announced plans to buy AZ Electronic Materials, which supplies high-tech materials for the electronics industry, for about 1.6 billion pounds ($2.6 billion).Pharmaceutical and high-tech materials company Merck said Thursday that it will offer 403.5 pence ($6.61) in cash per AZ share.
Under the civil penalty, Advanced Sterilization Products, a unit of J&J's Ethicon business,...
A report issued by the Pharmaceutical Research and Manufacturers of America says...
Forest Laboratories says it plans to cut about 500 jobs as part of a plan to trim $500 million...
Thirty-eight-year-old Syed "Farhan" Huda of Arlington entered the plea Monday in federal court in Alexandria on charges of importation fraud, selling misbranded drugs and distributing prescription drugs without a license.
Purdue Pharma said in a statement that the FDA accepted its application for Targiniq ER, an extended release tablet that combines oxycodone — the active ingredient in OxyContin — with the drug naloxone. The naloxone, which can reverse the effects of opioids, is intended to help make the medicine less likely to be abused.
Norway-based cancer drug maker Algeta ASA says it has received a preliminary takeover offer from Germany's Bayer AG that values the company at about $2.4 billion.Algeta said in a statement Tuesday that the offer is for 336 kroner ($55.11) per share; the company has nearly 44 million shares.
A French contraceptive maker says it will begin warning women that its morning-after pill is ineffective when taken by women who weigh more than 176 pounds. HRA Pharma head of women's health Frederique Welgryn told The Associated Press that the warning is the result of a 2011 study of levonorgestrel, the active compound in its Norlevo emergency contraceptive, and other pills like the Plan B One-Step.
The Food and Drug Administration is lifting severe safety restrictions on the former blockbuster diabetes pill Avandia, citing recent data suggesting that the much-debated medication does not increase the risk of heart attack.The repeal means patients will no longer have to enroll in a special registry to be eligible to receive the drug.
It is unclear whether the company or its executives will face criminal charges. Several lawyers who represent victims in lawsuits say health care companies charged with selling contaminated drugs often reach settlements with the federal government and agree to pay large fines.
Twenty-five pharmaceutical companies will pay the Louisina $88 million to resolve allegations they charged Louisiana's Medicaid program too much for their drugs, the final settlement reached in a 2010 lawsuit filed by Attorney General Buddy Caldwell.
A woman from Hawaii's Big Island is suing two companies who made and sold a dietary supplement that was pulled from shelves as state health officials investigate links to cases of hepatitis and liver failure.Lawyers for Everine Van Houten, 33, of Keaau, said Wednesday that she bought and used OxyELITE Pro, then began experiencing abdominal pain, fatigue and nausea one month later.
A Spanish court has ordered a German pharmaceutical company to pay compensation to 22 Spaniards born with disabilities after their mothers used the drug thalidomide during pregnancy decades ago. Madrid's provincial court Tuesday ordered the Gruenenthal Group in Spain to pay $26,300 for each percentage point of disability of victims recognized by Spain's Health Ministry.
State health officials have connected a Central Texas compounding pharmacy to a bacterial outbreak that sickened 17 patients in Corpus Christi hospitals earlier this year.Bacteria found in an unopened bag of sterile drugs at a local hospital was "indistinguishable" from that found in the blood of those sickened.
Last year, the agency took action against Roche after alleging the Swiss drug maker failed to properly report side effects for the medicines, including the cancer drugs Avastin, Herceptin and Xeloda. British authorities said there were "serious shortcomings" in how Roche AG reported potential problems.
The U.S. Food and Drug Administration said the products being recalled include those in the form of an injectable drug or an eye drop. The agency said the recall comes because of concerns about the quality control procedures that could pose a potential risk about the sterility of the products.
Growth in global prescription drug spending will slow to the lowest rate in decades as low-cost generic drugs continue replacing former blockbusters in the U.S. and Europe, where governments face new pressure to reduce health care spending, according to a new forecast.
Congress is taking a half step toward increasing federal oversight of so-called compounding pharmacies that custom mix medications in bulk, a year after a meningitis outbreak from contaminated pain injections killed at least 64 people and sickened hundreds of others.
Irish drugmaker Elan says its shareholders have approved the sale of the company to Perrigo Co. for $8.6 billion. The company said 99.5 percent of the shares voted at a special meeting were voted in favor of the sale. That made up 66 percent of its total shares.
Merck will cease active ingredient production at one of its plants in Puerto Rico in a blow to a city once considered a pharmaceutical hub.The company said Friday that production in Barceloneta will end by late 2014 as part of a global restructuring.
The Indianapolis company said Thursday it will spend $350 million to expand its insulin cartridge manufacturing in China, another $120 million for a similar improvement in France and $245 million to boost manufacturing capacity in Puerto Rico and Indianapolis.
Sealed Air President and CEO Jerome Peribere said in a statement Wednesday that the business "no longer presents a strategic fit for us." He added that the company will still make packaging products for the medical and pharmaceutical industry.
The bill cleared a parliamentary hurdle on a 97-1 vote, indicating its overwhelming support in the Senate. The legislation, passed by the House in September, also creates a national system for tracking prescription drugs from manufacturers to retail pharmacies. Final passage sending it to President Barack Obama for his signature could come as early as Wednesday.
The nation's first new heart disease prevention guidelines in a decade take a very different approach, focusing more broadly on risk and moving away from specific targets for cholesterol. The guidance offers doctors a new formula for estimating risk that includes age, gender, race and factors such as whether someone smokes.
A Lincoln County pharmaceutical plant will be closing, putting about 310 people out of work. Actavis PLC said Monday it will take until the middle of 2015 to close the plant, which makes creams and ointments.
The compounding pharmacy bill is intended to avert a repeat of last year's meningitis outbreak associated with the now-closed New England Compounding Center. Subsequent inspections found unsanitary conditions at the company's plant in Framingham, Mass., including mold and standing water.
Israel's Teva Pharmaceuticals Industries Ltd. says it has reached an agreement with the country's tax authority to pay roughly $718 million to settle a series of claims against the drug maker. The money will settle tax assessments on "trapped profits," earnings that result from special corporate tax breaks, and pay separate back taxes.
Thirty years ago, Congress passed the Orphan Drug Act as a way to lure pharmaceutical companies to develop drugs for rare diseases that had been "orphaned" — abandoned or ignored because they were unprofitable. The hope was that drugmakers would break even or post modest profits.
The Food and Drug Administration is seeking a rule change to allow generic drugmakers to quickly update their warning labels with new safety information for doctors and patients.Current regulations require generic drugs to bear the same labels as their branded counterparts.
- Page 1